Literature DB >> 32591400

Rapid HIV Progression Is Associated with Extensive Ongoing Somatic Hypermutation.

Ben S Wendel1, Yajing Fu2,3, Chenfeng He4, Stefany M Hernandez1, Mingjuan Qu4, Zining Zhang2,3, Yongjun Jiang2,3, Xiaoxu Han2,3, Junjie Xu2,3, Haibo Ding2,3, Ning Jiang5,6, Hong Shang7,3.   

Abstract

The Ab response to HIV is of great interest, particularly in the context of a protective vaccine and broadly neutralizing Abs, but research is typically geared toward elite controllers because of their ability to successfully control the virus. In this study, we studied the evolution of the Ab repertoire over the first year of HIV infection in people classified as rapid progressors (RP) compared with typical progressors. HIV RPs are an important yet understudied group of HIV patients classified by a rapid decline in CD4 counts and accelerated development of AIDS. We found that the global IgG somatic hypermutation load negatively correlated with disease progression, possibly because of exaggerated isotype switching of unmutated sequences in patients with low CD4 counts. We measured Ab sequence evolution over time using longitudinal samples taken during the early stages of infection and 1 year postinfection. Within clonal lineages spanning both timepoints, visit 2-derived sequences harbored considerably more mutations than their visit 1 relatives. Despite extensive ongoing somatic hypermutation, the initially strong signs of Ag selection pressure observed in visit 1-derived sequences decayed by visit 2. These data suggest that excessive immune activation in RPs leads to a hyperactive B cell response that fails to confer protection.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32591400      PMCID: PMC7372316          DOI: 10.4049/jimmunol.1901161

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.

Authors:  Kehmia Titanji; Vijayakumar Velu; Lakshmi Chennareddi; Matam Vijay-Kumar; Andrew T Gewirtz; Gordon J Freeman; Rama R Amara
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  A Shannon entropy analysis of immunoglobulin and T cell receptor.

Authors:  J J Stewart; C Y Lee; S Ibrahim; P Watts; M Shlomchik; M Weigert; S Litwin
Journal:  Mol Immunol       Date:  1997-10       Impact factor: 4.407

3.  Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Authors:  Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony S Fauci
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

4.  B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.

Authors:  Susan Moir; Clarisa M Buckner; Jason Ho; Wei Wang; Jenny Chen; Amy J Waldner; Jacqueline G Posada; Lela Kardava; Marie A O'Shea; Shyam Kottilil; Tae-Wook Chun; Michael A Proschan; Anthony S Fauci
Journal:  Blood       Date:  2010-09-13       Impact factor: 22.113

5.  Inadequate T follicular cell help impairs B cell immunity during HIV infection.

Authors:  Rafael A Cubas; Joseph C Mudd; Anne-Laure Savoye; Matthieu Perreau; Julien van Grevenynghe; Talibah Metcalf; Elizabeth Connick; Amie Meditz; Gordon J Freeman; Guillermo Abesada-Terk; Jeffrey M Jacobson; Ari D Brooks; Shane Crotty; Jacob D Estes; Giuseppe Pantaleo; Michael M Lederman; Elias K Haddad
Journal:  Nat Med       Date:  2013-03-10       Impact factor: 53.440

6.  Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.

Authors:  Angela Malaspina; Susan Moir; Jason Ho; Wei Wang; Melissa L Howell; Marie A O'Shea; Gregg A Roby; Catherine A Rehm; Joann M Mican; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

Review 7.  HIV-1-specific antibody responses during acute and chronic HIV-1 infection.

Authors:  Georgia D Tomaras; Barton F Haynes
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

8.  Quantifying selection in high-throughput Immunoglobulin sequencing data sets.

Authors:  Gur Yaari; Mohamed Uduman; Steven H Kleinstein
Journal:  Nucleic Acids Res       Date:  2012-05-27       Impact factor: 16.971

9.  Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection.

Authors:  Brodie Miles; Shannon M Miller; Joy M Folkvord; Abigail Kimball; Mastooreh Chamanian; Amie L Meditz; Tessa Arends; Martin D McCarter; David N Levy; Eva G Rakasz; Pamela J Skinner; Elizabeth Connick
Journal:  Nat Commun       Date:  2015-10-20       Impact factor: 14.919

10.  Accurate immune repertoire sequencing reveals malaria infection driven antibody lineage diversification in young children.

Authors:  Ben S Wendel; Chenfeng He; Mingjuan Qu; Di Wu; Stefany M Hernandez; Ke-Yue Ma; Eugene W Liu; Jun Xiao; Peter D Crompton; Susan K Pierce; Pengyu Ren; Keke Chen; Ning Jiang
Journal:  Nat Commun       Date:  2017-09-14       Impact factor: 14.919

View more
  4 in total

1.  Automated Extraction of Information From Texts of Scientific Publications: Insights Into HIV Treatment Strategies.

Authors:  Nadezhda Biziukova; Olga Tarasova; Sergey Ivanov; Vladimir Poroikov
Journal:  Front Genet       Date:  2020-12-22       Impact factor: 4.599

2.  Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving.

Authors:  Kenneth B Hoehn; Jackson S Turner; Frederick I Miller; Ruoyi Jiang; Oliver G Pybus; Ali H Ellebedy; Steven H Kleinstein
Journal:  Elife       Date:  2021-11-17       Impact factor: 8.140

3.  Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.

Authors:  Yuanhao Liang; Hongqing Lin; Emmanuel Enoch Dzakah; Shixing Tang
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

4.  Elite controllers long-term non progressors present improved survival and slower disease progression.

Authors:  Laura Capa; Rubén Ayala-Suárez; Humberto Erick De La Torre Tarazona; Juan González-García; Jorge Del Romero; José Alcamí; Francisco Díez-Fuertes
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.